Alberts DS - Search Results

1

Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.

Alberts DS, Peng YM, Chen HS, Struck RF. Alberts DS, et al. Br J Cancer. 1978 Aug;38(2):316-24. doi: 10.1038/bjc.1978.204. Br J Cancer. 1978. PMID: 698048 Free PMC article.

2

Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial.

Struck RF, Alberts DS, Horne K, Phillips JG, Peng YM, Roe DJ. Struck RF, et al. Among authors: alberts ds. Cancer Res. 1987 May 15;47(10):2723-6. Cancer Res. 1987. PMID: 3552204 Clinical Trial.

3

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.

Peng YM, Alberts DS, Chen HS, Mason N, Moon TE. Peng YM, et al. Among authors: alberts ds. Br J Cancer. 1980 Apr;41(4):644-7. doi: 10.1038/bjc.1980.110. Br J Cancer. 1980. PMID: 6155927 Free PMC article.

4

Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.

Struck RF, Alberts DS. Struck RF, et al. Among authors: alberts ds. Cancer Treat Rep. 1984 May;68(5):765-70. Cancer Treat Rep. 1984. PMID: 6722832

5

Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial.

Alberts DS, Mason-Liddil N, Plezia PM, Roe DJ, Dorr RT, Struck RF, Phillips JG. Alberts DS, et al. J Natl Cancer Inst. 1991 Dec 4;83(23):1739-42. doi: 10.1093/jnci/83.23.1739. J Natl Cancer Inst. 1991. PMID: 1770553 Clinical Trial.

6

Analysis and stability of retinol in plasma.

Peng YM, Xu MJ, Alberts DS. Peng YM, et al. Among authors: alberts ds. J Natl Cancer Inst. 1987 Jan;78(1):95-9. doi: 10.1093/jnci/78.1.95. J Natl Cancer Inst. 1987. PMID: 3467133

7

Plasma kinetics of oral retinol in cancer patients.

Goodman GE, Alberts DS, Peng YM, Beaudry J, Leigh SA, Moon TE. Goodman GE, et al. Among authors: alberts ds. Cancer Treat Rep. 1984 Sep;68(9):1125-33. Cancer Treat Rep. 1984. PMID: 6478452

8

Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model.

Alberts DS, Peng YM, Chen HS, Moon TE, Cetas TC, Hoeschele JD. Alberts DS, et al. J Natl Cancer Inst. 1980 Aug;65(2):455-61. J Natl Cancer Inst. 1980. PMID: 6931261

9

Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients.

Peng YM, Dalton WS, Alberts DS, Xu MJ, Lim H, Meyskens FL Jr. Peng YM, et al. Among authors: alberts ds. Int J Cancer. 1989 Jan 15;43(1):22-6. doi: 10.1002/ijc.2910430106. Int J Cancer. 1989. PMID: 2521335

10

In vivo and in vitro metabolism of the new anticancer drug bisantrene.

Peng YM, Alberts DS, Davis TP. Peng YM, et al. Among authors: alberts ds. Cancer Chemother Pharmacol. 1985;14(1):15-20. doi: 10.1007/BF00552718. Cancer Chemother Pharmacol. 1985. PMID: 3965156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

616 results

Search Page